CONTOL OF GENE EXPRESSION Flashcards
TOPIC 8
GENE MUTATION
change in base sequence of DNA
occurs during DNA replication
MUTANGENIC AGENTS
chemical or radiation that
increases mutation rate
.Base analogs: can substitute for base eg. 5-bromouracil can substitute for Thymine, but pairs w/Guanine instead of Alanine
.Altering bases: eg. alkylating agents add an alkyl to Guanine so changing its structure so that it pairs w/Thymine instead of Cytosine
.Altering DNA structure: eg. Ultra Violet radiation can cause adjacent Thymines to pair
ADDITION MUTATION
One extra base is added to the DNA sequence
causes all subsequent codons to be altered-frameshift
DELETION MUTATION
One base is deleted in the DNA sequence
causes all subsequent codons to be altered-frameshift
SUBSITUTION MUTATION
One base in DNA sequence is changed
no frameshift
only one codon changes
may have no impact due to degenerate genetic code
INVERTED MUTATION
section of bases detach from DNA sequence and re-join inverted
results in different amino acids being coded for in this region
DUPLICATION MUTATION
One base is duplicated at least once in sequence causes frameshift to right
TRANSLOCATION MUTATION
section of bases on one chromosome detaches and attaches to different chromosome
FRAMESHIFT
change in all the codons after point of mutation each base shifts left or right one position
IMPACT OF GENE MUTATIONS ON PROTEINS
- DNA base sequence
- mRNA codons
- amino acid sequence
- ionic/H/disulphide bonds
- tertiary structure
MUTATIONS HAVING NO EFFECT ON PROTEINS
Some mutations, such as substitutions, change only one triplet code in DNA-degenerate nature of genetic code this means that sequence of amino acids will not change
CHANGE IN AMINO ACID SEQUENCE COULD CAUSE
.May affect location of ionic/hydrogen/disulphide bond between R groups
.Change tertiary structure of protein
.May create nonfunctional protein
NON-FUNCTIONING PROTIEN
Protein w/different primary and tertiary structure- shape is changed it cannot carry out its function + prevent enzyme-substrate complexes from forming
STEM CELLS
undifferentiated cells that can continually divide and become specialised
TOTIPOTENT STEM CELLS
divide and produce any type of body cell
.Only present for limited time in first few divisions of mammalian embryo
.During development not all stem cell genes are expressed, so some are not transcribed or translated to proteins
.genes that are expressed lead to synthesis of proteins that determine cell structure and function-cell is now specialised and this is irreversible
PLURIPOTENT STEM CELL
Embryonic stem cells that can divide in unlimited numbers and develop to most of body’s cell types
can be used to treat human disorders, as they can differentiate to any body cell- get from 4-5 day old embryos that are spare from being used in IVF In vitro fertilisation treatment and rest of embryo is destroyed leads to ethical concerns regarding their use in research and treatment
MULTI-POTENT STEM CELL
Adult cells that can develop into limited number of cell types
have an operation to obtain bone marrow cells from donor that can develop to red blood cells or white blood cells
Can be used to replace variety of different cell types but it is limited-Requires donation of stem cells from genetically compatible donor – reduces chance of rejection, but rejection is still possible
Reliance on donors is an issue due to lack of suitable donors
Has less ethical issues as donors are usually consenting adults
UNIPOTENT STEM CELLS
Can only differentiate to one type of cell
E.g. Cardiomyocytes are highly specialised heart muscle cells- are very specialised, they cannot regenerate by mitosis themselves- formed from one type of unipotent stem cell that divides and differentiates to cardiomyocyte
IPS BEING USED IN RESEARCH + MEDICINE
.Take somatic adult specialised cells, and infect them w/modified virus w/genes coding for transcription factors so that cells become pluripotent
.Transcription factors attach to promoter region of DNA and stimulate RNA polymerase to stimulate transcription
.cells divide and differentiate to desired cells
IPS BEING TRANPLANTED
cells modified come from patient themselves- reduces chance of rejection when new cells are transplanted back in
EVALUATING USE OF STEM CELLS IN TREATING HUMAN DISORDER
Benefits: All stem cell treatments in medicine provide long term treatment as they continuously divide
Stem cells could be used to grow organs to save lives, or replace eye tissue
Bone marrow stem cells are already being used to treat leukaemia and have been used to cure HIV
Issues: Obtaining embryonic stem cells involves destruction of an embryo
Better to use adult stem cells e.g. iPS which could possibly be made from patient’s own cells-cells continuously dividing increases risk of uncontrollable cell division and production of tumours
nonfunctioning cells must be destroyed e.g. by chemotherapy treatment, before new functioning stem cells are injected – this can be painful and increase chance of infection
GENE EXPRESSION
ability of gene to be transcribed to mRNA and translated to polypeptide
PROMOTOR
section of DNA before gene where RNA Polymerase binds
TRANSCRIPTION FACTORS
proteins which bind to promotor region on DNA they move from cytoplasm to nucleus and stimulate RNA polymerase to produce mRNA + Inhibit binding of RNA polymerase preventing production of mRNA
ACTIVATORS
increase rate of transcription eg. Help RNA polymerase bind
REPRESSORS
decrease rate of transcription eg. Bind to start of gene and prevent RNA polymerase from binding
OESTROGEN
initiate transcription of target genes
small, hydrophobic hormone-means it is lipid soluble and can diffuse through phospholipid bilayers of membranes to all cells
Only target cells contain oestrogen receptor ERα in cytoplasm
ERα is also a transcription factor but is only ‘activated’ when oestrogen binds
When oestrogen binds to ERα oestrogen receptor in cytoplasm, it changes shape
ERα oestrogen receptor can now enter nucleus and bind to promoter region of one of its target genes, stimulating RNA polymerase to transcribe that target gene
MIRNAS
formed as hair-pin bends of RNA but processed to single strands about 22 to 26 nucleotides long- single strands become incorporated to protein-based RISC
SIRNAS
formed as long double-stranded molecule and then diced to smaller fragments about 21 to 25 base pairs long- One of their strands becomes incorporated to protein-based RISC
HOW RNAI INHIBIT TRANSLATION MRNA
1.DNA produces miRNA or siRNA in nucleus
2.RNAi moves from nucleus to cytoplasm
3.RNAi unwinds to become single stranded
4.RNAi binds to protein to form RISC
5.single stranded siRNA or miRNA binds to target mRNA molecule by complementary base pairing
6.prevents mRNA from attaching to ribosome and being translated
7.Enzymes may then hydrolyse mRNA
THERAPUTIC APPPLICATION OF SIRNAS
.siRNAs created against viral genetic material will signal for their degradation and stop the virus from using host’s cellular machinery to replicate itself
.siRNAs can be used in cancer treatment by targeting oncogenes that have been expressed or unregulated
reduces number of proteins produced that can lead to cancer or that maintain cancerous growth
EPIGENTICS
heritable change in gene function
without changing DNA base sequence
caused by changes in environment
can inhibit transcription
INCREASED METHYLATION OF DNA
Methyl groups –CH3 are attached to gene (Could be the result of diet/stress/smoking/food availability)
Hypermethylation of promoter prevents transcription factors from binding
RNA Polymerase is not stimulated- gene is not transcribed, and mRNA is not made + gene is not expressed
DECREASED ACETYLATION ASSOCIATION OF HISTONES
Acetyl groups –COCH3 are removed which condenses chromatin-Transcription factors cannot bind to promoter region- RNA Polymerase is not stimulated
gene can’t be transcribed so mRNA is not made + gene is not expressed